Epigenetics in Cardiovascular Disease

    Epigenetics has been initially studied in patients with CVD for its prominent role in inflammation and vascular involvement Furthermore, epigenetic studies in cardiovascular medicine revealed a significant number of modifications affecting the development and progression of CVD.  Epigenomics are involved in cardiovascular risk factors such as smoking, diabetes, hypertension and age.

 

  • Cardiac hypertrophy
  • Heart failure
  • Arrhythmias

Related Conference of Epigenetics in Cardiovascular Disease

October 30-31, 2025

Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

Rome, Italy
November 17-18, 2025

18th International Conference on Human Genomics and Genomic Medicine

Paris, France
March 09-10, 2026

21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

Singapore City, Singapore
April 16-17, 2026

19th World Congress on Stem Cell Research

Tokyo, Japan
April 23-24, 2026

9th Annual Conference on Stem Cell and Regenerative Medicine

Dubai, UAE
May 04-05, 2026

14th World Congress on Human Genetics and Genetic Diseases

Paris, France
May 25-26, 2026

20th International Conference on Regenerative Repair and Medicine

Madrid, Spain
June 08-09, 2026

9th Global Conference on Cell and Gene Therapy

Rome, Italy
June 15-16, 2026

22nd Global Summit on Stem Cell & Regenerative Medicine

Amsterdam, Netherlands
June 15-16, 2026

13th World Congress on Epigenetics and Chromosome

Paris, France
June 18-19, 2026

16th International Conference on Human Genetics and Genetic Diseases

Singapore City, Singapore
June 18-19, 2026

19th International Conference on Genomics & Pharmacogenomics

Singapore City, Singapore
September 25-26, 2025

6th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Epigenetics in Cardiovascular Disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in